Zwi Schlesinger

Rationale and design of a secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease (the bezafibrate infarction prevention trial)

Uri Goldbourt, Solomon Behar, Henrietta Reicher-Reiss et al. · The American Journal of Cardiology · 1993 · 157 citations

Metabolic Syndrome, Secondary Prevention Trial, Cardiovascular Disease +8

Cerebrovascular accident complicating acute myocardial infarction: Incidence, clinical significance, and short-long-term mortality rates

Solomon Behar, David Tanné, Edward Abinader et al. · The American Journal of Medicine · 1991 · 76 citations

Thrombosis, Cardiovascular Disease, Ischemic Stroke +11

The prognostic significance of angina pectoris preceding the occurrence of a first acute myocardial infarction in 4166 consecutive hospitalized patients

Solomon Behar, Henrietta Reicher-Reiss, Edward G. Abinader et al. · American Heart Journal · 1992 · 69 citations

Thrombosis, Cardiovascular Disease, Myocardial Infarction +9

Malignant arrhythmias in relation to values of serum potassium in patients with acute myocardial infarction

A Friedensohn, Hedy E. Faibel, Osnath Bairey et al. · International Journal of Cardiology · 1991 · 42 citations

Cardiovascular Disease, Malignant Arrhythmias, Myocardial Infarction +9

Repeat infusions of recombinant tissue-type plasminogen activator in patients with acute myocardial infarction and early recurrent myocardial ischemia

Gabriel I. Barbash, Hanoch Hod, Arie Roth et al. · Journal of the American College of Cardiology · 1990 · 36 citations

Thrombosis, Cardiovascular Disease, Fibrinolysis +8